Ask AI
ProCE Banner Series

The Next Frontier: Rapid AST to Optimize Care of Patients With Bloodstream Infections

Lead the way to the “next frontier” of care for patients with bloodstream infections as you learn from a multidisciplinary panel comprised of an ID physician, ID pharmacist, and microbiologist. Learn as they elucidate strategies for the timely susceptibility of Gram-negative organisms in patients with sepsis, describe the capabilities of rapid phenotypic AST platforms regarding patient outcomes and antimicrobial stewardship, and discuss strategies for the optimal implementation of rapid AST for Gram-negative BSIs into clinical practice.

Not an official event of IDWeek. Not sponsored, endorsed, or accredited by IDWeek.

 

  ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is intended for ID specialists, including physicians, pharmacists, nurse practitioners, and other HCPs who provide care for patients with BSIs. 

All Events

The Next Frontier: Rapid AST to Optimize Care of Patients With Bloodstream Infections

Upcoming Events

October

19

2025

10:00 AM - 11:30 AM Eastern Time (ET)

In-personVirtual

Omni Atlanta Hotel at Centennial Park, 190 Marietta St NW, Atlanta, Georgia 30303

Topics

Antimicrobial stewardship

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners regarding the optimal use of rapid phenotypic AST for the management of patients with BSIs.

Target Audience
This activity is intended for ID specialists, including physicians, pharmacists, nurse practitioners, and other HCPs who provide care for patients with BSIs. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Explain the potential benefits of rapid phenotypic AST for patients with Gram-negative BSIs

  • Utilize rapid genotypic and phenotypic AST results to inform antibiotic selection for patients with Gram-negative BSIs

  • Formulate strategies for optimal integration of rapid phenotypic AST into clinical practice, including incorporation into antimicrobial stewardship workflow

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.25 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-25-326-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.com to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC, in partnership with ProCE

Clinical Care Options, LLC

Supporters

Supported by an educational grant from bioMérieux.

bioMérieux

Partners

ProCE

ProCE Banner

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191